Immunitybio Inc. Earnings

Immunitybio Inc.’s revenue jumped 41192.5% since last year same period to $16.52Mn in the Q1 2025. On a quarterly growth basis, Immunitybio Inc. has generated 118.71% jump in its revenue since last 3-months.

Immunitybio Inc.’s net profit jumped 3.33% since last year same period to $-129.65Mn in the Q1 2025. On a quarterly growth basis, Immunitybio Inc. has generated -119.14% fall in its net profits since last 3-months.

Immunitybio Inc.’s net profit margin jumped 99.77% since last year same period to -784.92% in the Q1 2025. On a quarterly growth basis, Immunitybio Inc. has generated -0.2% fall in its net profit margins since last 3-months.

Immunitybio Inc.’s earning per share (EPS) estimates for the current quarter stand at -0.11 - a 31.25% jump from last quarter’s estimates.

Immunitybio Inc.’s earning per share (EPS) estimates for the current year stand at -0.11.

Immunitybio Inc.’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q2 2025. This indicates that the Immunitybio Inc. has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.